|
|
Other links at Articles > Business of Medicine |
| 3. |
Ethics, Evidence, and Cost in Newborn Screening
|
|
|
What are the ethical and policy issues that arise in debates on public newborn screening programs? The experience in Mississippi serves to highlight an important ethical issue in child health policy.
The Hastings Center Report
|
| 4. |
FDA Approvals: Cymbalta
|
|
|
The FDA has approved a new indication for duloxetine HCl delayed-release capsules (Cymbalta). Medscape Medical News
|
|
|